相似文献
1
The Society for Immunotherapy of Cancer Biomarkers Task Force recommendations review.
Semin Cancer Biol. 2018 Oct;52(Pt 2):12-15. doi: 10.1016/j.semcancer.2017.09.006. Epub 2017 Sep 22.
2
Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation.
J Immunother Cancer. 2016 Nov 15;4:76. doi: 10.1186/s40425-016-0178-1. eCollection 2016.
3
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.
J Immunother Cancer. 2017 May 16;5:44. doi: 10.1186/s40425-017-0243-4. eCollection 2017.
4
Systematic evaluation of immune regulation and modulation.
J Immunother Cancer. 2017 Mar 21;5:21. doi: 10.1186/s40425-017-0223-8. eCollection 2017.
5
Immuno-oncology biomarkers 2010 and beyond: perspectives from the iSBTc/SITC biomarker task force.
J Transl Med. 2010 Dec 7;8:130. doi: 10.1186/1479-5876-8-130.
6
Biomarkers for Checkpoint Inhibition.
Am Soc Clin Oncol Educ Book. 2017;37:205-209. doi: 10.1200/EDBK_175463.
7
SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art.
J Immunother Cancer. 2018 Dec 4;6(1):138. doi: 10.1186/s40425-018-0453-4.
8
SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery.
J Immunother Cancer. 2020 Dec;8(2). doi: 10.1136/jitc-2020-000705.
9
Biomarkers for Immunotherapy: Current Developments and Challenges.
Am Soc Clin Oncol Educ Book. 2016;35:e493-503. doi: 10.1200/EDBK_160766.
10
Immunotherapy biomarkers 2016: overcoming the barriers.
J Immunother Cancer. 2017 Mar 21;5(1):29. doi: 10.1186/s40425-017-0225-6.
引用本文的文献
1
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations.
Nat Rev Immunol. 2024 Jun;24(6):399-416. doi: 10.1038/s41577-023-00973-8. Epub 2023 Dec 6.
2
Deciphering the Dynamic Complexities of the Liver Microenvironment - Toward a Better Understanding of Immune-Mediated liver Injury Caused by Immune Checkpoint Inhibitors (ILICI).
AAPS J. 2021 Aug 16;23(5):99. doi: 10.1208/s12248-021-00629-2.
3
Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile.
Front Immunol. 2021 Mar 11;12:596646. doi: 10.3389/fimmu.2021.596646. eCollection 2021.
4
Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee.
J Immunother Cancer. 2020 Nov;8(2). doi: 10.1136/jitc-2020-001583.
5
Prediction of therapeutic outcome and survival in a transgenic mouse model of pancreatic ductal adenocarcinoma treated with dendritic cell vaccination or CDK inhibitor using MRI texture: a feasibility study.
Am J Transl Res. 2020 May 15;12(5):2201-2211. eCollection 2020.
6
Reader-free ELISPOT assay for immuno-monitoring in peptide-based cancer vaccine immunotherapy.
Biomed Rep. 2020 May;12(5):244-250. doi: 10.3892/br.2020.1289. Epub 2020 Mar 5.
7
Single-cell technologies for profiling T cells to enable monitoring of immunotherapies.
Curr Opin Chem Eng. 2018 Mar;19:142-152. doi: 10.1016/j.coche.2018.01.003. Epub 2018 Mar 6.
8
The role of automated cytometry in the new era of cancer immunotherapy.
Mol Clin Oncol. 2018 Oct;9(4):355-361. doi: 10.3892/mco.2018.1701. Epub 2018 Aug 20.
本文引用的文献
1
Immunotherapy biomarkers 2016: overcoming the barriers.
J Immunother Cancer. 2017 Mar 21;5(1):29. doi: 10.1186/s40425-017-0225-6.
2
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.
J Immunother Cancer. 2017 May 16;5:44. doi: 10.1186/s40425-017-0243-4. eCollection 2017.
3
Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation.
J Immunother Cancer. 2016 Nov 15;4:76. doi: 10.1186/s40425-016-0178-1. eCollection 2016.
4
Validation of biomarkers to predict response to immunotherapy in cancer: Volume II - clinical validation and regulatory considerations.
J Immunother Cancer. 2016 Nov 15;4:77. doi: 10.1186/s40425-016-0179-0. eCollection 2016.
5
Biomarkers immune monitoring technology primer: Immunoscore® Colon.
J Immunother Cancer. 2016 Sep 20;4:57. doi: 10.1186/s40425-016-0161-x. eCollection 2016.
6
Multiplexed tissue biomarker imaging.
J Immunother Cancer. 2016 Feb 16;4:9. doi: 10.1186/s40425-016-0115-3. eCollection 2016.
7
Novel technologies and emerging biomarkers for personalized cancer immunotherapy.
J Immunother Cancer. 2016 Jan 19;4:3. doi: 10.1186/s40425-016-0107-3. eCollection 2016.
8
Immune Monitoring Technology Primer: protein microarray ('seromics').
J Immunother Cancer. 2016 Jan 19;4:2. doi: 10.1186/s40425-016-0106-4. eCollection 2016.
9
nCounter(®) PanCancer Immune Profiling Panel (NanoString Technologies, Inc., Seattle, WA).
J Immunother Cancer. 2015 Dec 15;3:42. doi: 10.1186/s40425-015-0088-7. eCollection 2015.
10
Quantitative real-time PCR assisted cell counting (qPACC) for epigenetic - based immune cell quantification in blood and tissue.
J Immunother Cancer. 2015 Nov 17;3:46. doi: 10.1186/s40425-015-0087-8. eCollection 2015.
Zotero 插件